Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
IBKR | INTERACTIVE BROKERS GROUP INC | $153.51 | $43.81 | 250.39% | 21.96x | 21.64x | 3.20x | 3.91x | 9.11x | $8.68B | 52.27% | $4.28B | 39.59 | $29.64B | 26.03 | ||
RWAY | RUNWAY GROWTH FINANCE CORP | $9.03 | N/A | N/A | 4.78x | 6.06x | 2.43x | 0.66x | N/A | $69.76M | 19.88% | $514.87M | 13.25 | $883.83M | 7.48 | ||
VYGR | VOYAGER THERAPEUTICS INC | $3.21 | N/A | N/A | -2.84x | -2.28x | 2.31x | 0.59x | N/A | -$18.83M | -10.19% | $299.76M | 5.20 | $146.70M | -2.46 | ||
TRVI | TREVI THERAPEUTICS INC | $6.02 | N/A | N/A | -12.81x | -11.11x | N/A | 5.84x | N/A | -$38.29M | -6.25% | $99.64M | 0.98 | $548.96M | -11.49 | ||
TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | $13.31 | N/A | N/A | -9.18x | 5.38x | 0.91x | 2.81x | N/A | $749.00M | 4.97% | $5.37B | 4.75 | $29.87B | 27.73 | ||
CTNM | CONTINEUM THERAPEUTICS INC | $4.95 | N/A | N/A | -2.27x | -2.12x | N/A | 0.65x | N/A | -$33.34M | -34.81% | $198.07M | 10.23 | $112.38M | -2.73 | ||
SYRE | SPYRE THERAPEUTICS INC | $13.57 | N/A | N/A | -4.27x | -4.28x | N/A | 1.58x | N/A | -$157.41M | -24.66% | $517.80M | 11.01 | $728.52M | -3.50 | ||
TALO | TALOS ENERGY INC | $7.15 | N/A | N/A | -16.25x | -6.36x | 0.64x | 0.47x | N/A | $454.84M | 36.22% | $2.76B | 15.72 | $2.31B | 1.84 | ||
KAPA | KAIROS PHARMA LTD | $0.91 | N/A | N/A | -3.97x | N/A | N/A | 3.19x | N/A | -$3.96M | -38.16% | $4.78M | 0.42 | $13.95M | -5.43 | ||
EVH | EVOLENT HEALTH INC | $8.48 | N/A | N/A | -10.47x | 282.67x | 0.38x | 0.99x | N/A | -$6.13M | -0.63% | $1.00B | 8.73 | $1.60B | 19.96 | ||
ELVN | ENLIVEN THERAPEUTICS INC | $16.22 | N/A | N/A | -8.58x | -7.06x | N/A | 2.57x | N/A | -$73.24M | -9.59% | $309.85M | 6.58 | $670.68M | -7.61 | ||
JAKK | JAKKS PACIFIC INC | $18.09 | $22.04 | -17.92% | 5.53x | 5.26x | 0.28x | 0.84x | 1.47x | $27.70M | 14.21% | $240.33M | 22.29 | $188.02M | 3.72 | ||
HUMA | HUMACYTE INC | $1.45 | N/A | N/A | -1.15x | -1.94x | N/A | -4.27x | N/A | -$99.69M | -58.00% | -$52.67M | -0.45 | $209.67M | -1.59 | ||
PASG | PASSAGE BIO INC | $0.36 | N/A | N/A | -0.33x | -0.46x | N/A | 0.36x | N/A | -$47.99M | -221.79% | $61.26M | 1.01 | $10.15M | -0.16 | ||
TNGX | TANGO THERAPEUTICS INC | $1.38 | N/A | N/A | -1.16x | -1.01x | 3.58x | 0.75x | N/A | -$132.26M | -87.75% | $199.52M | 1.83 | $116.15M | -0.94 | ||
LENZ | LENZ THERAPEUTICS INC | $24.11 | N/A | N/A | -10.30x | -8.59x | N/A | 3.25x | N/A | -$59.86M | -11.67% | $204.08M | 9.59 | $644.60M | -12.97 | ||
TSHA | TAYSHA GENE THERAPIES INC | $1.45 | N/A | N/A | -4.03x | -4.31x | 43.94x | 4.16x | N/A | -$81.60M | -22.48% | $71.53M | 0.29 | $216.92M | -2.50 | ||
XNCR | XENCOR INC | $10.60 | N/A | N/A | -2.96x | -3.70x | 6.24x | 1.10x | N/A | -$208.29M | -30.21% | $677.61M | 10.42 | $937.59M | -5.14 | ||
IAC | IAC INC | $32.90 | N/A | N/A | -5.07x | 249.24x | 0.72x | 0.49x | N/A | $301.84M | 11.02% | $5.58B | 66.98 | $2.91B | -13.37 | ||
STRW | STRAWBERRY FIELDS REIT INC | $11.03 | $30.82 | -64.21% | 19.35x | N/A | 0.67x | 7.42x | 0.14x | -$78.57M | -99.98% | $18.17M | 2.55 | $712.84M | 9.75 | ||
FCNCA | FIRST CITIZENS BANCSHARES INC | $1,684.73 | N/A | N/A | 8.89x | 10.14x | 2.59x | 1.03x | N/A | $1.70B | 7.05% | $22.23B | 1,549.87 | $38.76B | 10.41 | ||
GHRS | GH RESEARCH PLC | $9.17 | N/A | N/A | -12.23x | -8.59x | N/A | 2.67x | N/A | -$48.69M | -10.21% | $178.95M | 3.44 | $376.93M | -9.94 | ||
APGE | APOGEE THERAPEUTICS INC | $32.85 | N/A | N/A | -9.95x | -7.25x | N/A | 2.73x | N/A | -$172.33M | -9.50% | $716.79M | 12.99 | $1.82B | -10.12 | ||
LCTX | LINEAGE CELL THERAPEUTICS INC | $0.40 | N/A | N/A | -4.44x | N/A | 8.51x | 1.17x | N/A | -$23.66M | -29.50% | $78.38M | 0.39 | $48.07M | -2.67 | ||
FLL | FULL HOUSE RESORTS INC | $2.92 | N/A | N/A | -2.52x | -9.73x | 0.35x | 2.59x | N/A | -$38.74M | -37.95% | $40.50M | 1.16 | $591.93M | 13.20 | ||
ATUS | ALTICE USA INC | $2.21 | N/A | N/A | -10.05x | -7.48x | 0.11x | -2.18x | N/A | $48.76M | 4.80% | -$469.24M | -1.02 | $26.08B | 7.91 |